Elara Capital

Hindustan Unilever (Accumulate)

CMP: ₹1,672.35

Target: ₹1,872

Hindustan Unilever is engaged in fast-moving consumer goods business comprising home and personal care, foods and refreshments.

Hindustan Unilever’s net sales was up 9.3 per cent y-o-y at ₹9,940 crore, 2 per cent lower than estimates. The domestic business posted volume growth of +7 per cent y-o-y (versus our estimates of 8 per cent y-o-y) and value growth of +9 per cent y-o-y. Home care at 13 per cent y-o-y and largely volume-led and food & refreshments at +10 per cent y-o-y lifted growth while personal care (+7 per cent) lagged. Gross margin contracted 27 bps y-o-y on crude inflation and rupee devaluation against dollar by 9.8 per cent y-o-y. EBITDA was up 13.3 per cent y-o-y at ₹2,320 crore, 5.5 per cent lower than our estimates. EBITDA margin expanded 82.5 bps y-o-y on cost rationalisation: employee expenses were down 35 bps y-o-y, ad spend 63 bps y-o-y and other expenses 11 bps y-o-y.

Adjusted PAT was up 13.8 per cent y-o-y at ₹1,580 crore, 5.6 per cent lower than estimates. At a CMP HUL is trading at 45x FY21E P/E, almost giving no value to the Glaxo portfolio, as the merged entity will have an EPS of ₹41.2. We reiterate ‘Accumulate’ with a TP ₹ 1,872 on 45x merged EPS of ₹41.2.

comment COMMENT NOW